201 related articles for article (PubMed ID: 33931365)
1. Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers.
De Marini P; Cazzato RL; Garnon J; Dalili D; Leonard-Lorant I; Leclerc L; Autrusseau PA; Auloge P; Weiss J; Tricard T; Lang H; Gangi A
Diagn Interv Imaging; 2021 Sep; 102(9):531-538. PubMed ID: 33931365
[TBL] [Abstract][Full Text] [Related]
2. Safety and Oncologic Outcomes of Magnetic Resonance Imaging-Guided Cryoablation of Renal Cell Carcinoma: A 10-Year Single-Center Experience.
Cazzato RL; De Marini P; Leonard-Lorant I; Leclerc L; Auloge P; Tricard T; Dalili D; Garnon J; Lang H; Gangi A
Invest Radiol; 2021 Mar; 56(3):153-162. PubMed ID: 32897930
[TBL] [Abstract][Full Text] [Related]
3. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients.
Bhagavatula SK; Tuncali K; Shyn PB; Levesque VM; Chang SL; Silverman SG
Radiology; 2020 Sep; 296(3):687-695. PubMed ID: 32633677
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
[TBL] [Abstract][Full Text] [Related]
6. Safety and Oncologic Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma Recurrences in the Ipsilateral Kidney Following Partial Nephrectomy.
Rossi J; Cazzato RL; de Marini P; Auloge P; Autrusseau PA; Dalili D; Tricard T; Poussot B; Garnon J; Lang H; Gangi A
Cardiovasc Intervent Radiol; 2022 May; 45(5):656-664. PubMed ID: 35274173
[TBL] [Abstract][Full Text] [Related]
7. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
[No Abstract] [Full Text] [Related]
9. Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety.
Schmit GD; Atwell TD; Leibovich BC; Callstrom MR; Kurup AN; Woodrum DA; Charboneau JW
AJR Am J Roentgenol; 2010 Dec; 195(6):1418-22. PubMed ID: 21098204
[TBL] [Abstract][Full Text] [Related]
10. Computed tomography-guided percutaneous cryoablation of T1b renal tumors: safety, functional and oncological outcomes.
Grange R; Tradi F; Izaaryene J; Daidj N; Brunelle S; Walz J; Gravis G; Piana G
Int J Hyperthermia; 2019; 36(1):1065-1071. PubMed ID: 31648584
[No Abstract] [Full Text] [Related]
11. Long-term outcomes of CT-guided percutaneous cryoablation of T1a and T1b renal cell carcinoma.
Spiliopoulos S; Marzoug A; Ra H; Arcot Ragupathy SK
Diagn Interv Radiol; 2021 Jul; 27(4):524-528. PubMed ID: 34313238
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
[TBL] [Abstract][Full Text] [Related]
13. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience.
Tanagho YS; Bhayani SB; Kim EH; Figenshau RS
J Endourol; 2013 Dec; 27(12):1477-86. PubMed ID: 24283518
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Contrast-Enhanced Ultrasound Scan (CEUS) and MRI in the follow-up of cryoablation for small renal tumors. Experience on 25 cases.
Zeccolini G; Del Biondo D; Cicero C; Casarin A; Guarise A; Celia A
Urologia; 2014; 81 Suppl 23():S1-8. PubMed ID: 24665032
[TBL] [Abstract][Full Text] [Related]
16. MRI- Versus CT-Guided Renal Tumor Cryoablation: Is There a Difference?
Cazzato RL; De Marini P; Mayer T; Leclerc L; Leonard-Lorant I; Dalili D; Weiss J; Koch G; Autrusseau PA; Garnon J; Lang H; Gangi A
Cardiovasc Intervent Radiol; 2023 Jul; 46(7):901-910. PubMed ID: 37225969
[TBL] [Abstract][Full Text] [Related]
17. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study.
Georgiades CS; Rodriguez R
Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1494-9. PubMed ID: 24385225
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
20. Oncologic outcomes and safety of percutaneous cryoablation for biopsy-proven renal cell carcinoma up to 4 cm in diameter: a prospective observational study.
Gobara H; Hiraki T; Iguchi T; Matsui Y; Sakurai J; Uka M; Tomita K; Komaki T; Kobayasi Y; Araki M; Watanabe T; Kanazawa S
Int J Clin Oncol; 2021 Mar; 26(3):562-568. PubMed ID: 33174078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
